Phase 4 N=100 Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement
Obesity · Arthritis
Primary: Assessment of Delirium — 0; 0 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=478 Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Asthma
Primary: Occurrence of One or More Asthma Exacerbations (All Treatment Steps [Steps 2-5]) — 11.3; 21.0 Percent of adjusted prevalence — p=0.03
Phase 4 N=16 A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy
Chronic Diabetic Macular Edema
Primary: Changes in Best Corrected Visual Acuity From Baseline — 3.5; 0.9 Best Corrected VA Letter Score
Phase 4 N=100 HIV Non Occupational Post-Exposure Prophylaxis (PEP)
HIV Infections
Primary: Medication Regimen Completion Rates — 57; 28; 15 participants
Phase 4 N=751 Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B
Chronic Hepatitis B
Primary: Percentage of Participants With HBsAg Loss at Week 72 Following Treatment With 48 Weeks of TDF Plus Peg-IFN Combination Versus Peg-IFN Alone for 48 Weeks or TDF Alone…
Phase 4 N=127 Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)
Parkinson's Disease · Motor Symptoms · Akinesia
Primary: Change From Baseline in Average Daily "Time to on" ("TTO") by Subject Diary. — 60.86; 23.72; 37.14 minutes
Phase 4 N=228 A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.
Colorectal Cancer
Primary: Percentage of Participants With an Adverse Event (AE), Serious AE, or Death Due to an AE — 56.1; 6.1; 0.4 percentage of participants
Phase 4 N=185 Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines
Glabellar Rhytides
Primary: Percentage of Subjects With a ≥ 1-Grade Improvement From Day 1 in the Investigator Assessed Facial Wrinkle Scale of Glabellar Rhytides at Maximum Contraction — 97.1…
Phase 4 N=90 Effect of Laryngeal Mask Cuff Pressure in Geriatric Patients
Anaesthesia
Primary: Postoperative Pharyngolaryngeal Morbidity Postoperative 1.Hour — 1; 1 units on a scale
Phase 4 N=300 This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa
Hepatitis B
Primary: Anti-HBs Immune Response — 272 Subject
Phase 4 N=90 Low Dose Ketamine Versus Morphine for Moderate to Severe Pain in the Emergency Department
Pain
Primary: Numeric Rating Scale of Pain — 3.93; 4.07 Units on a scale
Phase 4 N=50 Cannabinoid Control of Fear Extinction Neural Circuits in Humans
Healthy Participants
Primary: BOLD Signal Measured by Functional Magnetic Resonance Imaging (fMRI) — 0.1631; 0.5079 parameter estimates (arbitrary units)
Phase 4 N=47 Beneficial Effect of Probiotics on Chronic Kidney Disease
Chronic Kidney Disease
Primary: the Occurrence of Cardiovascular Event and Peritonitis Events — 0; 0; 0; 0 participants — p=>0.05
Phase 4 N=53 Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia
Ventricular Tachycardia
Primary: Percentage of Participants Free From VT at 1 Year Post-Treatment — 62 percentage of participants free from VT
Phase 4 N=53 Intranasal Fentanyl as an Analgesic for Cystoscopic Procedures
Pain
Primary: Pre Procedure 0 - 10 Pain Numerical Rating Scale — 0; 0; 7; 5 0 - 10 Pain Numerical Rating Scale